Literature DB >> 1415652

Arterial pressure lability and renal sympathetic nerve activity are dissociated in SAD rats.

C Barres1, S J Lewis, H J Jacob, M J Brody.   

Abstract

The purpose of this study was to determine whether the sympathetic nervous system drives the high variability of arterial pressure (AP) observed after sinoaortic denervation (SAD) in rats. One or fourteen days after SAD, rats were instrumented chronically to record mean AP (MAP), heart rate (HR), and renal sympathetic nerve activity (RSNA) in the conscious unrestrained state. Acute SAD increased MAP, HR, RSNA, and variability of MAP and decreased variability of both HR and RSNA. In rats with chronic SAD, variability of MAP remained high, whereas MAP, HR, RSNA, and variability of HR and RSNA returned to normal levels. Correlation analysis showed that, in sham-operated rats, AP and RSNA were negatively correlated in 90% of cases. In contrast, rats with both acute and chronic SAD exhibited only 30% negative and 25% positive correlations. These results indicate that 1) low AP variability in intact rats results from baroreflex-mediated inversely related fluctuations in RSNA and HR and 2) high variability of AP after acute and chronic SAD is correlated infrequently with RSNA. Because lability is reduced by interventions that block the sympathetic nervous system, we conclude that lability of AP associated with SAD appears to be mediated largely by a permissive role of sympathetic activity.

Entities:  

Mesh:

Year:  1992        PMID: 1415652     DOI: 10.1152/ajpregu.1992.263.3.R639

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Linear modelling analysis of baroreflex control of arterial pressure variability in rats.

Authors:  Bruno Chapuis; Emmanuelle Vidal-Petiot; Valérie Oréa; Christian Barrès; Claude Julien
Journal:  J Physiol       Date:  2004-07-02       Impact factor: 5.182

2.  Neural control of arterial pressure variability in the neuromuscularly blocked rat.

Authors:  Xiaorui Tang; Tian Hu
Journal:  Eur J Appl Physiol       Date:  2011-09-23       Impact factor: 3.078

3.  Short-term haemodynamic variability in the conscious areflexic rat.

Authors:  R Létienne; C Barrès; C Cerutti; C Julien
Journal:  J Physiol       Date:  1998-01-01       Impact factor: 5.182

4.  Statistical relationships between systolic blood pressure and heart rate and their functional significance in conscious rats.

Authors:  M Ducher; C Cerutti; M P Gustin; C Z Paultre
Journal:  Med Biol Eng Comput       Date:  1994-11       Impact factor: 2.602

Review 5.  Possible Breathing Influences on the Control of Arterial Pressure After Sino-aortic Denervation in Rats.

Authors:  Mateus R Amorim; George Miguel P R Souza; Benedito H Machado
Journal:  Curr Hypertens Rep       Date:  2018-01-22       Impact factor: 5.369

Review 6.  Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.

Authors:  I H Zucker; J L Liu
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

7.  The dmNTS is not the source of increased blood pressure variability in baroreflex denervated rats.

Authors:  Xiaorui Tang; Barry R Dworkin
Journal:  Auton Neurosci       Date:  2009-03-13       Impact factor: 3.145

8.  Involvement of vasodilator mechanisms in arterial pressure lability after sino-aortic baroreceptor denervation in rat.

Authors:  Z Q Zhang; C Barrès; C Julien
Journal:  J Physiol       Date:  1995-01-15       Impact factor: 5.182

9.  Cardiac damage after lesions of the nucleus tractus solitarii.

Authors:  Ameya Nayate; Steven A Moore; Robert Weiss; Otar M Taktakishvili; Li-Hsien Lin; William T Talman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-11-19       Impact factor: 3.619

10.  Arterial baroreceptor reflex counteracts long-term blood pressure increase in the rat model of renovascular hypertension.

Authors:  Vitaly A Tsyrlin; Michael M Galagudza; Nataly V Kuzmenko; Michael G Pliss; Nataly S Rubanova; Yury I Shcherbin
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.